Literature DB >> 17229690

A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism.

Matteo Porotto1, Micaela Fornabaio, Glen E Kellogg, Anne Moscona.   

Abstract

The hemagglutinin-neuraminidase (HN) protein of paramyxoviruses carries out three discrete activities that each affect the ability of HN to promote viral fusion and entry: receptor binding, receptor cleaving (neuraminidase), and triggering of the fusion protein. The interrelationship between the receptor binding and fusion-triggering functions of HN has not been clear. For human parainfluenza type 3 (HPIV3), one bifunctional site on HN can carry out both receptor binding and neuraminidase activities, and this site's receptor binding can be inhibited by the small receptor analog zanamivir. We now report experimental evidence, complemented by computational data, for a second receptor binding site near the HPIV3 HN dimer interface. This second binding site can mediate receptor binding even in the presence of zanamivir, and it differs from the second receptor binding site of the paramyxovirus Newcastle disease virus in its function and its relationship to the primary binding site. This second binding site of HPIV3 HN is involved in triggering F. We suggest that the two receptor binding sites on HPIV3 HN each contribute in distinct ways to virus-cell interaction; one is the multifunctional site that contains both binding and neuraminidase activities, and the other contains binding activity and also is involved in fusion promotion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229690      PMCID: PMC1866072          DOI: 10.1128/JVI.02617-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase.

Authors:  S Crennell; T Takimoto; A Portner; G Taylor
Journal:  Nat Struct Biol       Date:  2000-11

2.  Probing the sialic acid binding site of the hemagglutinin-neuraminidase of Newcastle disease virus: identification of key amino acids involved in cell binding, catalysis, and fusion.

Authors:  Helen Connaris; Toru Takimoto; Rupert Russell; Susan Crennell; Ibrahim Moustafa; Allen Portner; Garry Taylor
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 3.  Hydrophobicity: is LogP(o/w) more than the sum of its parts?

Authors:  G Eugene Kellogg; D J Abraham
Journal:  Eur J Med Chem       Date:  2000 Jul-Aug       Impact factor: 6.514

4.  Inhibition of hendra virus fusion.

Authors:  M Porotto; L Doctor; P Carta; M Fornabaio; O Greengard; G E Kellogg; A Moscona
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

5.  Paramyxovirus receptor-binding molecules: engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site.

Authors:  Matteo Porotto; Micaela Fornabaio; Olga Greengard; Matthew T Murrell; Glen E Kellogg; Anne Moscona
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  Computationally accessible method for estimating free energy changes resulting from site-specific mutations of biomolecules: systematic model building and structural/hydropathic analysis of deoxy and oxy hemoglobins.

Authors:  J C Burnett; P Botti; D J Abraham; G E Kellogg
Journal:  Proteins       Date:  2001-02-15

7.  The importance of being exhaustive. Optimization of bridging structural water molecules and water networks in models of biological systems.

Authors:  Glen E Kellogg; Deliang L Chen
Journal:  Chem Biodivers       Date:  2004-01       Impact factor: 2.408

8.  Human parainfluenza virus type 3 HN-receptor interaction: effect of 4-guanidino-Neu5Ac2en on a neuraminidase-deficient variant.

Authors:  M Porotto; O Greengard; N Poltoratskaia; M A Horga; A Moscona
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

9.  Alpha complementation of LacZ in mammalian cells.

Authors:  P Moosmann; S Rusconi
Journal:  Nucleic Acids Res       Date:  1996-03-15       Impact factor: 16.971

10.  The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA.

Authors:  O Greengard; N Poltoratskaia; E Leikina; J Zimmerberg; A Moscona
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

View more
  60 in total

Review 1.  Modes of paramyxovirus fusion: a Henipavirus perspective.

Authors:  Benhur Lee; Zeynep Akyol Ataman
Journal:  Trends Microbiol       Date:  2011-04-20       Impact factor: 17.079

2.  Paramyxoviruses: different receptors - different mechanisms of fusion.

Authors:  Ronald M Iorio; Paul J Mahon
Journal:  Trends Microbiol       Date:  2008-03-17       Impact factor: 17.079

3.  A histidine switch in hemagglutinin-neuraminidase triggers paramyxovirus-cell membrane fusion.

Authors:  Anuja Krishnan; Santosh K Verma; Prashant Mani; Rahul Gupta; Suman Kundu; Debi P Sarkar
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

4.  Kinetic dependence of paramyxovirus entry inhibition.

Authors:  Matteo Porotto; Christine C Yokoyama; Gianmarco Orefice; Han-Sung Kim; Mohamed Aljofan; Bruce A Mungall; Anne Moscona
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

5.  Creation and Evaluation of a Single-chain Antibody Tetramer that Targets Brain Endothelial Cells.

Authors:  Xiaobin Zhang; Xin Xiang Wang; Eric V Shusta
Journal:  AIChE J       Date:  2014-04-01       Impact factor: 3.993

Review 6.  Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme.

Authors:  Judith M White; Sue E Delos; Matthew Brecher; Kathryn Schornberg
Journal:  Crit Rev Biochem Mol Biol       Date:  2008 May-Jun       Impact factor: 8.250

7.  Premature activation of the paramyxovirus fusion protein before target cell attachment with corruption of the viral fusion machinery.

Authors:  Shohreh F Farzan; Laura M Palermo; Christine C Yokoyama; Gianmarco Orefice; Micaela Fornabaio; Aurijit Sarkar; Glen E Kellogg; Olga Greengard; Matteo Porotto; Anne Moscona
Journal:  J Biol Chem       Date:  2011-07-28       Impact factor: 5.157

8.  In Vivo Efficacy of Measles Virus Fusion Protein-Derived Peptides Is Modulated by the Properties of Self-Assembly and Membrane Residence.

Authors:  T N Figueira; L M Palermo; A S Veiga; D Huey; C A Alabi; N C Santos; J C Welsch; C Mathieu; B Horvat; S Niewiesk; A Moscona; M A R B Castanho; M Porotto
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

9.  N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site.

Authors:  Vasiliy P Mishin; Makiko Watanabe; Garry Taylor; John Devincenzo; Michael Bose; Allen Portner; Irina V Alymova
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

10.  Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entry.

Authors:  Matteo Porotto; Barry Rockx; Christine C Yokoyama; Aparna Talekar; Ilaria Devito; Laura M Palermo; Jie Liu; Riccardo Cortese; Min Lu; Heinz Feldmann; Antonello Pessi; Anne Moscona
Journal:  PLoS Pathog       Date:  2010-10-28       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.